Sumitomo Chemical India Ltd. (SUMICHEM) AI Stock Analysis

• Market Cap: ₹204.10B
• Dividend Yield: 0.26%
• Average Volume (3M): 14.60K
• Price to Earnings (P/E): 38.4
• Beta (1Y): 1.17
• Revenue Growth: 8.69%
• EPS Growth: 12.26%
• Country: IN
• Employees: 1,649
• Sector: Basic Materials
• Sector Strength: 58
• Industry: Agricultural Inputs
• EPS (TTM): 1.65
• Shares Outstanding: 499,145,720
• 10 Day Avg. Volume: 20,149
• 30 Day Avg. Volume: 14,601
• PEG Ratio: 1.48
• Price to Book (P/B): 9.51
• Price to Sales (P/S): 8.76
• P/FCF Ratio: 56.64
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 61 Neutral
• Price Target: ₹432.00 ▼(-7.82% Downside)

Sumitomo Chemical India Ltd. demonstrates strong financial performance, which is the primary driver of its stock score. However, technical analysis indicates bearish momentum, and valuation metrics suggest the stock may be overvalued. These factors contribute to a moderate overall stock score.

Positive Factors

Sustained Profitability Margins

Consistently high gross (>30%) and net (>16%) margins indicate durable pricing power and efficient manufacturing in agrochemicals. These margins provide structural buffers against input volatility, support reinvestment in products and R&D, and sustain long-term cash generation.

Conservative Balance Sheet

A low debt-to-equity profile and equity ratio above 70% provide lasting financial flexibility. Conservative leverage reduces refinancing risk across crop cycles, supports countercyclical investment, and preserves capacity to fund capex or absorb shocks without excessive external financing.

Strong Cash Flow Conversion

Reliable free cash flow and improving operating cash flow-to-net-income metrics show durable cash conversion from operations. This ability funds working capital, targeted capex and potential bolt-on investments while lowering dependence on external capital over multi-quarter horizons.

Negative Factors

Modest Top-line and EPS Growth

Low single-digit revenue and EPS growth constrains the company's ability to expand scale and margins over time. Without faster product introductions or market share gains, modest growth may limit earnings leverage and the capacity to materially improve returns to shareholders.

Need for Better Cost Management and Returns

The firm-level assessment explicitly flags cost control and shareholder-return shortcomings. Persisting inefficiencies or conservative payout policies could reduce long-term ROE and investor-aligned capital allocation, limiting sustained shareholder value creation over multiple quarters.

Seasonality and Product-Mix Exposure

Revenue and profitability depend structurally on crop seasons and product mix. This cyclicality makes sales and cash flows sensitive to weather, planting patterns and crop prices, increasing volatility and complicating long-term planning absent broader geographic or product diversification.

Sumitomo Chemical India Ltd. Business Overview & Revenue Model

Company Description

Sumitomo Chemical India Limited engages in the manufacture and sale of household and public health insecticides, agricultural pesticides, and animal nutrition products in India and internationally. It operates through two segments, Agro Chemicals and Others. The company offers crop protection products, such as insecticides, herbicides, fungicides, and miticides; animal nutrition and plant growth regulators; fumigants and rodenticides; weedicides; and biological products. It also exports its products. The company was incorporated in 2000 and is headquartered in Mumbai, India. Sumitomo Chemical India Limited is a subsidiary of Sumitomo Chemical Company Limited.

How the Company Makes Money

SUMICHEM generates revenue through several key streams, primarily by selling agrochemical products and specialty chemicals to a diverse customer base, including farmers, agricultural businesses, and industrial manufacturers. The company's revenue model is bolstered by strategic partnerships with local distributors and retailers, which enhance its market reach across India. Additionally, SUMICHEM benefits from research and development initiatives that lead to the introduction of new and innovative products, allowing it to capture a larger market share. The company also engages in export activities, providing its products to international markets, further diversifying its income sources.

Sumitomo Chemical India Ltd. Financial Statement Overview

Summary

Sumitomo Chemical India Ltd. exhibits strong financial health with consistent revenue growth and healthy profit margins. The balance sheet is solid with low leverage, and cash flows are strong, indicating effective cash management. However, there is room for improvement in cost management and shareholder returns.

Income Statement

Sumitomo Chemical India Ltd. shows strong financial performance with consistent revenue growth, as evidenced by a significant increase in total revenue from the previous year. The company maintains healthy profit margins, with a gross profit margin of over 30% and a net profit margin exceeding 16%. The EBIT and EBITDA margins also reflect operational efficiency. These factors indicate a robust and profitable income statement, although slightly fluctuating gross profit suggests potential room for improvement in cost management.

Balance Sheet

The company's balance sheet is solid, with a low debt-to-equity ratio indicating conservative leverage. The equity ratio above 70% demonstrates financial stability and a strong capital structure. However, the return on equity, while positive, shows potential for improvement to maximize shareholder value. Overall, the company maintains a healthy balance sheet with manageable liabilities and a robust equity base.

Cash Flow

The cash flow statement displays a positive trajectory, with consistent free cash flow generation and an improving operating cash flow to net income ratio. The free cash flow to net income ratio indicates efficient cash conversion, though slightly decreasing operating cash flow warrants monitoring. The company manages capital expenditures well, supporting sustainable cash flow growth.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	33.66B	31.49B	28.44B	35.11B	30.61B	26.45B
Gross Profit	13.46B	12.70B	10.49B	12.24B	11.36B	9.74B
EBITDA	6.71B	6.10B	4.53B	6.47B	5.82B	4.74B
Net Income	5.57B	5.05B	3.70B	5.02B	4.24B	3.45B
Balance Sheet
Total Assets	0.00	39.64B	33.13B	33.69B	30.10B	26.70B
Cash, Cash Equivalents and Short-Term Investments	12.62B	12.59B	8.91B	5.63B	5.75B	5.32B
Total Debt	0.00	518.93M	302.49M	339.72M	375.84M	326.35M
Total Liabilities	-29.05B	10.59B	8.69B	9.87B	10.82B	11.29B
Stockholders Equity	29.05B	29.01B	24.42B	23.82B	19.27B	15.41B
Cash Flow
Free Cash Flow	0.00	4.87B	6.93B	2.70B	1.08B	3.82B
Operating Cash Flow	0.00	5.17B	7.57B	3.89B	2.22B	4.25B
Investing Cash Flow	0.00	-4.57B	-4.20B	-3.27B	-2.90B	-2.58B
Financing Cash Flow	0.00	-679.20M	-3.37B	-725.45M	-626.38M	-470.64M

Sumitomo Chemical India Ltd. Technical Analysis

• Technical Analysis Sentiment: Neutral
• Last Price: 468.65
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:SUMICHEM, the sentiment is Neutral. The current price of 468.65 is above the 20-day moving average (MA) of 427.93, above the 50-day MA of 446.74, and below the 200-day MA of 515.33, indicating a bearish trend. The MACD of -12.09 indicates Positive momentum. The RSI at 44.62 is Neutral, neither overbought nor oversold. The STOCH value of 34.89 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for IN:SUMICHEM.

Sumitomo Chemical India Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
HSCL	74 Outperform	₹232.24B	32.32	―	0.12%	-2.24%	31.43%
GNFC	70 Outperform	₹68.54B	10.78	―	3.68%	-7.53%	42.74%
RALLIS	63 Neutral	₹53.43B	31.99	―	0.92%	0.91%	18.12%
Sector *	61 Neutral	$10.43B	7.12	-0.05%	2.87%	2.86%	-36.73%
SUMICHEM	61 Neutral	₹204.10B	38.41	―	0.26%	8.69%	12.26%
BAYERCROP	61 Neutral	₹200.83B	32.98	―	1.57%	8.92%	5.06%
BASF	59 Neutral	₹157.67B	42.03	―	0.51%	0.43%	-42.29%

Sumitomo Chemical India Ltd. Corporate Events

Sumitomo Chemical India Unveils Investor Presentation for December 2025 Results

Sumitomo Chemical India Ltd. has released an investor presentation detailing its financial results for the quarter and nine months ended 31 December 2025, describing the period as “a year of resurgence.” The disclosure, made in line with SEBI’s listing regulations, is aimed at updating shareholders and the broader market on the company’s performance trajectory, and the presentation has been submitted to both BSE and NSE for publication on their websites, signaling increased transparency and engagement with investors at a potentially pivotal point in its recovery.

Sumitomo Chemical India Releases Unaudited Q3 and Nine-Month FY2025 Results

Sumitomo Chemical India Ltd. has released its unaudited standalone and consolidated financial results for the quarter and nine months ended 31 December 2025, following approval by its Board of Directors. The disclosure, made in compliance with SEBI listing regulations and supported by limited review reports from BSR & Co. LLP, provides investors and other market participants with updated financial performance data that will inform assessments of the company’s operating trajectory and valuation ahead of the close of the financial year.

Sumitomo Chemical India Files Clean Q3 FY2025 Integrated Financial Results

Sumitomo Chemical India Ltd. has submitted its integrated financial filing for the quarter and nine months ended 31 December 2025, in line with SEBI’s revised disclosure framework and recent circulars from BSE and NSE. The company has released its unaudited standalone and consolidated financial results and confirmed that there are no applicable deviations in the use of issue proceeds, no outstanding defaults on loans or debt securities, no reportable related-party transactions under the prescribed format, and no audit qualifications requiring disclosure, signalling regulatory compliance and a clean financial and governance profile for the period.

Sumitomo Chemical India Reports Insider Trading Code Violation, Fines Senior Executive

Sumitomo Chemical India Limited has reported to the BSE and NSE a violation of its Code of Conduct under SEBI’s Prohibition of Insider Trading Regulations by a designated person. The company disclosed that Kaushal Shah, General Manager of its Bhavnagar plant, pledged 250 shares of the company during the week ended 14 November 2025 without obtaining mandatory pre-clearance from the Compliance Officer, and consequently imposed a monetary penalty of ₹5,000 on him, signaling enforcement of internal governance and compliance standards for designated employees.

Sumitomo Chemical India Releases Q2 & H1 FY ’26 Earnings Call Transcript

Sumitomo Chemical India Limited has released the written transcript of its earnings call held on October 28, 2025, discussing the financial performance for the quarter and half-year ending September 30, 2025. This announcement provides stakeholders with detailed insights into the company’s financial health and strategic direction, reinforcing its commitment to transparency and effective communication with investors.